91 related articles for article (PubMed ID: 1902971)
1. Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line.
Kéri G; Balogh A; Szöke B; Teplán I; Csuka O
Tumour Biol; 1991; 12(2):61-7. PubMed ID: 1902971
[TBL] [Abstract][Full Text] [Related]
2. Novel antitumor peptide hormones and their effect on signal transduction.
Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011
[TBL] [Abstract][Full Text] [Related]
3. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
4. Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
Nicholson RI; Kéri G
Tumour Biol; 1992; 13(1-2):44-50. PubMed ID: 1534181
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor.
Chamson-Reig A; Sorianello EM; Catalano PN; Fernández MO; Pignataro OP; Libertun C; Lux-Lantos VA
Endocrinology; 2003 Jul; 144(7):2957-66. PubMed ID: 12810551
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists.
Eidne KA; Flanagan CA; Harris NS; Millar RP
J Clin Endocrinol Metab; 1987 Mar; 64(3):425-32. PubMed ID: 3029154
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter.
Bonfil D; Chuderland D; Kraus S; Shahbazian D; Friedberg I; Seger R; Naor Z
Endocrinology; 2004 May; 145(5):2228-44. PubMed ID: 14736735
[TBL] [Abstract][Full Text] [Related]
8. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
9. Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct.
Kaiser UB; Katzenellenbogen RA; Conn PM; Chin WW
Mol Endocrinol; 1994 Aug; 8(8):1038-48. PubMed ID: 7527898
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
[TBL] [Abstract][Full Text] [Related]
11. Biphasic action of cyclic adenosine 3',5'- monophosphate in gonadotropin-releasing hormone (GnRH) analog-stimulated hormone release from GH3 cells stably transfected with GnRH receptor complementary deoxyribonucleic acid.
Stanislaus D; Arora V; Awara WM; Conn PM
Endocrinology; 1996 Mar; 137(3):1025-31. PubMed ID: 8603570
[TBL] [Abstract][Full Text] [Related]
12. Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells.
Mullen P; Bramley T; Menzies G; Miller B
Eur J Cancer; 1993; 29A(2):248-52. PubMed ID: 8380699
[TBL] [Abstract][Full Text] [Related]
13. Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells.
Finch AR; Green L; Hislop JN; Kelly E; McArdle CA
J Clin Endocrinol Metab; 2004 Apr; 89(4):1823-32. PubMed ID: 15070951
[TBL] [Abstract][Full Text] [Related]
14. Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen.
Günthert AR; Gründker C; Olota A; Läsche J; Eicke N; Emons G
Eur J Endocrinol; 2005 Oct; 153(4):613-25. PubMed ID: 16189183
[TBL] [Abstract][Full Text] [Related]
15. Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells.
Kim KY; Choi KC; Park SH; Chou CS; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2004 Jun; 89(6):3020-6. PubMed ID: 15181093
[TBL] [Abstract][Full Text] [Related]
16. The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation.
Han XB; Conn PM
Endocrinology; 1999 May; 140(5):2241-51. PubMed ID: 10218977
[TBL] [Abstract][Full Text] [Related]
17. Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells.
Blankenstein MA; Henkelman MS; Klijn JG
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1493-9. PubMed ID: 3938397
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum.
Ohta H; Sakamoto H; Satoh K
Cancer Lett; 1998 Dec; 134(1):111-8. PubMed ID: 10381137
[TBL] [Abstract][Full Text] [Related]
19. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis.
Kleinman D; Douvdevani A; Schally AV; Levy J; Sharoni Y
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):96-102. PubMed ID: 8296852
[TBL] [Abstract][Full Text] [Related]
20. Signaling and antiproliferative effects mediated by GnRH receptors after expression in breast cancer cells using recombinant adenovirus.
Everest HM; Hislop JN; Harding T; Uney JB; Flynn A; Millar RP; McArdle CA
Endocrinology; 2001 Nov; 142(11):4663-72. PubMed ID: 11606431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
